Men and Women Differ in Pain Drug Abuse Risks

Key points
- There are distinct gender differences underlying the risks for abuse of prescription pain drugs, according to a Harvard study published in The Journal of Pain, the peer review journal of the American Pain Society, www.ampainsoc.org and www.jpain.org.
- The researchers assumed that predictors of misuse would be different in men and women, with misuse among women closely related to psychological distress.
- “Since little has been published about gender differences and misuse of prescription pain medication, it is valuable to document whether risk factors for abuse are gender-specific to some degree,” said Robert N.
- The results of the study showed that men and women have similar frequencies of aberrant drug behavior, but gender differences were found in risk factors for misuse of opioid medications.
There are distinct gender differences underlying the risks for abuse of prescription pain drugs, according to a Harvard study published in The Journal of Pain, the peer review journal of the American Pain Society, www.ampainsoc.org and www.jpain.org.
For the research, 662 chronic non-cancer pain patients who take opioid pain medications were surveyed with standard pain assessment questionnaires to examine rates and characteristics of problematic opioid use, profiles of risk factors for potential misuse, and predictive associations between risk factors and subsequent misuse behavior. The researchers assumed that predictors of misuse would be different in men and women, with misuse among women closely related to psychological distress.
“Since little has been published about gender differences and misuse of prescription pain medication, it is valuable to document whether risk factors for abuse are gender-specific to some degree,” said Robert N. Jamison, PhD, lead author and a clinical psychologist at Harvard’s Brigham and Women’s Hospital. “This could help clinicians be more proactive in adopting risk-prevention interventions.”
The results of the study showed that men and women have similar frequencies of aberrant drug behavior, but gender differences were found in risk factors for misuse of opioid medications.
“Our analysis showed that drug misuse by women is motivated more by emotional issues and psychological distress while in men this behavior usually stems from problematic social and behavioral problems that lead to substance abuse,” said Jamison. “Further, women who misuse pain drugs are more likely to admit to being sexually or physically abused or have a history of psychiatric or psychological problems.”
The study recommended that for women being treated with opioids for chronic non-cancer pain with evidence of significant affective stress, clinicians should treat the mood disorder and counsel on the dangers of relying on opioids to reduce stress and improve sleep. For men, closer monitoring of known or suspected behavioral problems, frequent urine screens, pill counts and compliance monitoring are recommended to help reduce risks for drug misuse.
--
Source: American Pain Society
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsE-cigarettes may promote illicit drug use and addiction
Like conventional cigarettes, electronic cigarettes (or e-cigarettes) may function as a "gateway drug" - a drug that lowers the threshold for addiction to other substances, such as marijuana and cocaine - according to…
5 September 2014
NewsArmy drug users twice as likely to use synthetic marijuana as regular marijuana
Social work researchers from the University of Washington have found that among a group of active-duty Army personnel who use illicit drugs, the most abused substance is synthetic marijuana, which is harder to detect…
9 May 2014
NewsFDA rejects wider use of Xarelto drug
U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said on Friday. The companies had sought approval from…